KR870004997A - 테트라알킬 에테닐리덴 비스포스포네이트 및 이의 제조방법 - Google Patents
테트라알킬 에테닐리덴 비스포스포네이트 및 이의 제조방법 Download PDFInfo
- Publication number
- KR870004997A KR870004997A KR860009273A KR860009273A KR870004997A KR 870004997 A KR870004997 A KR 870004997A KR 860009273 A KR860009273 A KR 860009273A KR 860009273 A KR860009273 A KR 860009273A KR 870004997 A KR870004997 A KR 870004997A
- Authority
- KR
- South Korea
- Prior art keywords
- bisphosphonate
- ethenylidene
- ethenylidenebisphosphonate
- diethyl
- tri
- Prior art date
Links
- 229940122361 Bisphosphonate Drugs 0.000 title claims 63
- -1 ethenylidene bisphosphonate Chemical class 0.000 title claims 42
- 238000002360 preparation method Methods 0.000 title 1
- 150000004663 bisphosphonates Chemical class 0.000 claims 20
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 18
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 12
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 9
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 8
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 8
- 208000035473 Communicable disease Diseases 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 7
- 208000015181 infectious disease Diseases 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- KUFMXPZUZBPFCT-UHFFFAOYSA-N P(O)(OCOP(O)=O)=O Chemical compound P(O)(OCOP(O)=O)=O KUFMXPZUZBPFCT-UHFFFAOYSA-N 0.000 claims 4
- 229930040373 Paraformaldehyde Natural products 0.000 claims 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 4
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 229920002866 paraformaldehyde Polymers 0.000 claims 4
- 239000002904 solvent Substances 0.000 claims 4
- WWLDDKLYNMZAGO-UHFFFAOYSA-N 1-[1-diethoxyphosphorylethenyl(heptoxy)phosphoryl]oxyheptane Chemical compound CCCCCCCOP(=O)(C(=C)P(=O)(OCC)OCC)OCCCCCCC WWLDDKLYNMZAGO-UHFFFAOYSA-N 0.000 claims 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 3
- 150000001412 amines Chemical class 0.000 claims 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims 3
- 150000003335 secondary amines Chemical class 0.000 claims 3
- BRRCNRQMFCNJFJ-UHFFFAOYSA-N 1,1-bis(dimethoxyphosphoryl)ethene Chemical group COP(=O)(OC)C(=C)P(=O)(OC)OC BRRCNRQMFCNJFJ-UHFFFAOYSA-N 0.000 claims 2
- QKNVOARSKQINOG-UHFFFAOYSA-N 1-[1-dibutoxyphosphorylethenyl(ethoxy)phosphoryl]oxybutane Chemical compound CCCCOP(=O)(OCC)C(=C)P(=O)(OCCCC)OCCCC QKNVOARSKQINOG-UHFFFAOYSA-N 0.000 claims 2
- LRXHZJSAYHGONN-UHFFFAOYSA-N 1-[1-diethoxyphosphorylethenyl(2-methylpropoxy)phosphoryl]oxy-2-methylpropane Chemical class CCOP(=O)(OCC)C(=C)P(=O)(OCC(C)C)OCC(C)C LRXHZJSAYHGONN-UHFFFAOYSA-N 0.000 claims 2
- OJULIZFIMAJBBP-UHFFFAOYSA-N 1-[1-diethoxyphosphorylethenyl(hexoxy)phosphoryl]oxyhexane Chemical compound CCCCCCOP(=O)(C(=C)P(=O)(OCC)OCC)OCCCCCC OJULIZFIMAJBBP-UHFFFAOYSA-N 0.000 claims 2
- BSEIFGRIDJYFAK-UHFFFAOYSA-N 1-[1-diethoxyphosphorylethenyl(pentoxy)phosphoryl]oxypentane Chemical class CCCCCOP(=O)(C(=C)P(=O)(OCC)OCC)OCCCCC BSEIFGRIDJYFAK-UHFFFAOYSA-N 0.000 claims 2
- RCEQVJORUPLSDI-UHFFFAOYSA-N 1-[1-diheptoxyphosphorylethenyl(ethoxy)phosphoryl]oxyheptane Chemical compound CCCCCCCOP(=O)(OCC)C(=C)P(=O)(OCCCCCCC)OCCCCCCC RCEQVJORUPLSDI-UHFFFAOYSA-N 0.000 claims 2
- UNMIJWPQRWMDNY-UHFFFAOYSA-N 1-[1-diheptoxyphosphorylethenyl(methoxy)phosphoryl]oxyheptane Chemical compound CCCCCCCOP(=O)(OC)C(=C)P(=O)(OCCCCCCC)OCCCCCCC UNMIJWPQRWMDNY-UHFFFAOYSA-N 0.000 claims 2
- JIXKEPRDWBMMHC-UHFFFAOYSA-N 1-[1-dimethoxyphosphorylethenyl(pentoxy)phosphoryl]oxypentane Chemical class CCCCCOP(=O)(C(=C)P(=O)(OC)OC)OCCCCC JIXKEPRDWBMMHC-UHFFFAOYSA-N 0.000 claims 2
- VQVLOCATANQZTO-UHFFFAOYSA-N 1-[1-dimethoxyphosphorylethenyl(propoxy)phosphoryl]oxypropane Chemical class CCCOP(=O)(OCCC)C(=C)P(=O)(OC)OC VQVLOCATANQZTO-UHFFFAOYSA-N 0.000 claims 2
- SNBUENRTARHBSP-UHFFFAOYSA-N 1-[butoxy(1-dimethoxyphosphorylethenyl)phosphoryl]oxybutane Chemical compound CCCCOP(=O)(C(=C)P(=O)(OC)OC)OCCCC SNBUENRTARHBSP-UHFFFAOYSA-N 0.000 claims 2
- IPUAADANTWKVJD-UHFFFAOYSA-N 2-[1-di(propan-2-yloxy)phosphorylethenyl-propan-2-yloxyphosphoryl]oxypropane Chemical compound CC(C)OP(=O)(OC(C)C)C(=C)P(=O)(OC(C)C)OC(C)C IPUAADANTWKVJD-UHFFFAOYSA-N 0.000 claims 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- 239000003377 acid catalyst Substances 0.000 claims 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 claims 2
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims 2
- 239000002243 precursor Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 2
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 claims 1
- GONNHGGDGGQZEK-UHFFFAOYSA-N 1-[1-diethoxyphosphorylethenyl(propoxy)phosphoryl]oxypropane Chemical compound CCCOP(=O)(OCCC)C(=C)P(=O)(OCC)OCC GONNHGGDGGQZEK-UHFFFAOYSA-N 0.000 claims 1
- FHCFGDLVJNYPJI-UHFFFAOYSA-N 1-[1-diheptoxyphosphorylethenyl(heptoxy)phosphoryl]oxyheptane Chemical compound CCCCCCCOP(=O)(OCCCCCCC)C(=C)P(=O)(OCCCCCCC)OCCCCCCC FHCFGDLVJNYPJI-UHFFFAOYSA-N 0.000 claims 1
- HKKADJJAGXQYDC-UHFFFAOYSA-N 1-[1-dihexoxyphosphorylethenyl(ethoxy)phosphoryl]oxyhexane Chemical compound CCCCCCOP(=O)(OCC)C(=C)P(=O)(OCCCCCC)OCCCCCC HKKADJJAGXQYDC-UHFFFAOYSA-N 0.000 claims 1
- GZLLEOMLCAFFNW-UHFFFAOYSA-N 1-[1-dihexoxyphosphorylethenyl(methoxy)phosphoryl]oxyhexane Chemical compound CCCCCCOP(=O)(OC)C(=C)P(=O)(OCCCCCC)OCCCCCC GZLLEOMLCAFFNW-UHFFFAOYSA-N 0.000 claims 1
- MEMPCPNSANWRAX-UHFFFAOYSA-N 1-[1-dipentoxyphosphorylethenyl(ethoxy)phosphoryl]oxypentane Chemical compound CCCCCOP(=O)(OCC)C(=C)P(=O)(OCCCCC)OCCCCC MEMPCPNSANWRAX-UHFFFAOYSA-N 0.000 claims 1
- WMYKGKBIJXWWKJ-UHFFFAOYSA-N 1-[1-dipentoxyphosphorylethenyl(methoxy)phosphoryl]oxypentane Chemical compound CCCCCOP(=O)(OC)C(=C)P(=O)(OCCCCC)OCCCCC WMYKGKBIJXWWKJ-UHFFFAOYSA-N 0.000 claims 1
- KVDXSCYHEJVWIE-UHFFFAOYSA-N 1-[1-dipropoxyphosphorylethenyl(ethoxy)phosphoryl]oxypropane Chemical compound CCCOP(=O)(OCC)C(=C)P(=O)(OCCC)OCCC KVDXSCYHEJVWIE-UHFFFAOYSA-N 0.000 claims 1
- JAYPSOCTRCTPRH-UHFFFAOYSA-N 1-[1-dipropoxyphosphorylethenyl(methoxy)phosphoryl]oxypropane Chemical compound CCCOP(=O)(OC)C(=C)P(=O)(OCCC)OCCC JAYPSOCTRCTPRH-UHFFFAOYSA-N 0.000 claims 1
- NNVIDFQYLGCRQN-UHFFFAOYSA-N 1-[1-dipropoxyphosphorylethenyl(pentoxy)phosphoryl]oxypentane Chemical compound CCCCCOP(=O)(OCCCCC)C(=C)P(=O)(OCCC)OCCC NNVIDFQYLGCRQN-UHFFFAOYSA-N 0.000 claims 1
- XYENELGWZDQZFH-UHFFFAOYSA-N 1-[butoxy(1-diethoxyphosphorylethenyl)phosphoryl]oxybutane Chemical compound CCCCOP(=O)(OCCCC)C(=C)P(=O)(OCC)OCC XYENELGWZDQZFH-UHFFFAOYSA-N 0.000 claims 1
- ZZJJGHPXDZCCNE-UHFFFAOYSA-N 1-[butoxy(1-dipropoxyphosphorylethenyl)phosphoryl]oxybutane Chemical compound CCCCOP(=O)(OCCCC)C(=C)P(=O)(OCCC)OCCC ZZJJGHPXDZCCNE-UHFFFAOYSA-N 0.000 claims 1
- ILBNYNANQXYKOG-UHFFFAOYSA-N 1-[butoxy(dibutoxyphosphorylmethyl)phosphoryl]oxybutane Chemical compound CCCCOP(=O)(OCCCC)CP(=O)(OCCCC)OCCCC ILBNYNANQXYKOG-UHFFFAOYSA-N 0.000 claims 1
- STJWVOQLJPNAQL-UHFFFAOYSA-N 1-[diethoxyphosphorylmethyl(ethoxy)phosphoryl]oxyethane Chemical compound CCOP(=O)(OCC)CP(=O)(OCC)OCC STJWVOQLJPNAQL-UHFFFAOYSA-N 0.000 claims 1
- BWNLDSATZVDMRZ-UHFFFAOYSA-N 1-[diheptoxyphosphorylmethyl(heptoxy)phosphoryl]oxyheptane Chemical compound CCCCCCCOP(=O)(OCCCCCCC)CP(=O)(OCCCCCCC)OCCCCCCC BWNLDSATZVDMRZ-UHFFFAOYSA-N 0.000 claims 1
- NMMBDAYUXVALNI-UHFFFAOYSA-N 1-[dihexoxyphosphorylmethyl(hexoxy)phosphoryl]oxyhexane Chemical compound CCCCCCOP(=O)(OCCCCCC)CP(=O)(OCCCCCC)OCCCCCC NMMBDAYUXVALNI-UHFFFAOYSA-N 0.000 claims 1
- KINTZBMFUVCTNT-UHFFFAOYSA-N 1-[dipentoxyphosphorylmethyl(pentoxy)phosphoryl]oxypentane Chemical compound CCCCCOP(=O)(OCCCCC)CP(=O)(OCCCCC)OCCCCC KINTZBMFUVCTNT-UHFFFAOYSA-N 0.000 claims 1
- KIRAWZDATXLOAV-UHFFFAOYSA-N 1-[dipropoxyphosphorylmethyl(propoxy)phosphoryl]oxypropane Chemical compound CCCOP(=O)(OCCC)CP(=O)(OCCC)OCCC KIRAWZDATXLOAV-UHFFFAOYSA-N 0.000 claims 1
- VWXUGTRWNJRIGY-UHFFFAOYSA-N 1-[hydroxy(pentoxy)phosphoryl]ethenylphosphonic acid Chemical compound CCCCCOP(O)(=O)C(=C)P(O)(O)=O VWXUGTRWNJRIGY-UHFFFAOYSA-N 0.000 claims 1
- OPUSWQRACUDSJB-UHFFFAOYSA-N 1-diethoxyphosphoryl-1-[ethoxy(methoxy)phosphoryl]ethene Chemical compound CCOP(=O)(OC)C(=C)P(=O)(OCC)OCC OPUSWQRACUDSJB-UHFFFAOYSA-N 0.000 claims 1
- XVRONXGGGIAUJJ-UHFFFAOYSA-N 1-dihexoxyphosphorylethenyl(hexoxy)phosphinic acid Chemical compound CCCCCCOP(=O)(C(=C)P(=O)(OCCCCCC)OCCCCCC)O XVRONXGGGIAUJJ-UHFFFAOYSA-N 0.000 claims 1
- YJNUNLHEROFVNM-UHFFFAOYSA-N 1-dimethoxyphosphoryl-1-[ethoxy(methoxy)phosphoryl]ethene Chemical compound CCOP(=O)(OC)C(=C)P(=O)(OC)OC YJNUNLHEROFVNM-UHFFFAOYSA-N 0.000 claims 1
- BRZINLSZEIJGOW-UHFFFAOYSA-N 2-[1-di(propan-2-yloxy)phosphorylethenyl-methoxyphosphoryl]oxypropane Chemical compound CC(C)OP(=O)(OC)C(=C)P(=O)(OC(C)C)OC(C)C BRZINLSZEIJGOW-UHFFFAOYSA-N 0.000 claims 1
- ODTQUKVFOLFLIQ-UHFFFAOYSA-N 2-[di(propan-2-yloxy)phosphorylmethyl-propan-2-yloxyphosphoryl]oxypropane Chemical compound CC(C)OP(=O)(OC(C)C)CP(=O)(OC(C)C)OC(C)C ODTQUKVFOLFLIQ-UHFFFAOYSA-N 0.000 claims 1
- NJBCRXCAPCODGX-UHFFFAOYSA-N 2-methyl-n-(2-methylpropyl)propan-1-amine Chemical compound CC(C)CNCC(C)C NJBCRXCAPCODGX-UHFFFAOYSA-N 0.000 claims 1
- JKTORXLUQLQJCM-UHFFFAOYSA-N 4-phosphonobutylphosphonic acid Chemical group OP(O)(=O)CCCCP(O)(O)=O JKTORXLUQLQJCM-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 241000193403 Clostridium Species 0.000 claims 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 claims 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 206010017964 Gastrointestinal infection Diseases 0.000 claims 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims 1
- 241000604794 Ocotea foetens Species 0.000 claims 1
- 241000588769 Proteus <enterobacteria> Species 0.000 claims 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 1
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 241000194019 Streptococcus mutans Species 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000000551 dentifrice Substances 0.000 claims 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims 1
- 208000019836 digestive system infectious disease Diseases 0.000 claims 1
- 229940043279 diisopropylamine Drugs 0.000 claims 1
- LAWOZCWGWDVVSG-UHFFFAOYSA-N dioctylamine Chemical compound CCCCCCCCNCCCCCCCC LAWOZCWGWDVVSG-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 claims 1
- 125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 claims 1
- UWNADWZGEHDQAB-UHFFFAOYSA-N i-Pr2C2H4i-Pr2 Natural products CC(C)CCC(C)C UWNADWZGEHDQAB-UHFFFAOYSA-N 0.000 claims 1
- MBKDYNNUVRNNRF-UHFFFAOYSA-N medronic acid Chemical compound OP(O)(=O)CP(O)(O)=O MBKDYNNUVRNNRF-UHFFFAOYSA-N 0.000 claims 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- PXSXRABJBXYMFT-UHFFFAOYSA-N n-hexylhexan-1-amine Chemical compound CCCCCCNCCCCCC PXSXRABJBXYMFT-UHFFFAOYSA-N 0.000 claims 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 claims 1
- 239000000376 reactant Substances 0.000 claims 1
- 239000002453 shampoo Substances 0.000 claims 1
- 206010040872 skin infection Diseases 0.000 claims 1
- 239000000344 soap Substances 0.000 claims 1
- 208000019206 urinary tract infection Diseases 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
- 239000008096 xylene Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
- C07F9/4028—Esters of poly(thio)phosphonic acids containing no further substituents than -PO3H2 groups in free or esterified form
- C07F9/4031—Acyclic unsaturated derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (27)
- (a) 메탄올 에탄올로 이루어진 그룹중에서 선택된 알코올 용매중에서, 포름알데히드, 파라포름알데히드 및 트리옥산중에서 선택한 포름알데히드 또는 포름알데히드 전구체 약 20 내지 약 96몰%, 2급 아민 약 2 내지 약 40몰%, 및 일반식(I')의 테트라알킬메틸렌비스포스포네이트 2 내지 약 40몰%를 혼합하고;(b) 이 혼합물을 약 0.5 내지 약 200시간 동안 약 40 내지 약 80℃의 온도로 가열하고;(c) 상기 알코올 용매를 톨루엔, 벤젠 및 크실렌중에서 선택한 등량의 용매로 대체하고;(d) 파라 톨루엔설폰산 및 인산으로 이루어진 그룹중에서 선택한 산 촉매량을 가한 후, 이 혼합물을 약 2 내지 약 48시간 동안 반응시킴을 특징으로 하여, 일반식(I)의 테트라알킬 에테닐리덴 비스포스포네이트를 합성하는 방법상기식에서, R1, R2, R3및 R4는 C1내지 C7직쇄 또는 측쇄 알킬 중에서 독립적으로 선택한다.
- 제1항에 있어서, 단계(a)중 2급 아민이 피게리돈, 피페리딘, 디에틸아민, 디메틸아민, 벤질메틸아민, 디벤질아민, 디-n-부틸아민, 디시클로헥실아민, 디-n-헥실아민, 디이소부틸아민, 디이소프로필아민, 디-n-옥틸아민 및 피페라진 또는 그의 혼합물중에서 선택되고, 알코올 용매가 메탄올인 방법.
- 제2항에 있어서, 포름알데히드 전구체가 파라포름알데히드이고, 상기 파라포름알데히드의 양이 약 50내지 약 80몰%이며, 아민의 양이 약 10 내지 약 20몰%이고, 테트라알킬 메틸렌비스포스포네이트의 양이 약 10 내지 약 20몰%인 방법.
- 제3항에 있어서, 파라포름알데히드의 양이 약 50 내지 75몰%이고, 2급 아민의 양이 약 10 내지 약 15몰%이며, 테트라알킬메틸렌비스포스포네이트의 양이 약 10 내지 약 15몰%인 방법.
- 제4항에 있어서, 테트라알킬메틸렌비스포스포네이트가 테트메틸렌비스포스포네이트, 테트라에틸메틸렌비스포스포네이트, 테트라이소프로필메틸렌비스포스포네이트, 테트라-n-프로필메틸렌비스포스포네이트, 테트라-n-부틸메틸렌비스포스포스네이트, 테트라-n-펜틸메틸렌비스포스포네이트, 테트라-n-헥실메틸렌비스포스포네이트, 테트라-n-헵틸메틸렌비스포스포네이트, 디에틸디부틸메틸렌비스포스포네이트, 디메틸 디-n-프로필메틸렌비스포스포네이트, 디메틸디이소프로필메틸렌비스포스포네이트, 디메틸 디-n-부틸메틸렌비스포스포네이트, 디에틸디-n-프로필메틸렌비스포스포네이트, 디에틸디이소프로필메틸렌비스포스포네이트, 디에틸디메틸메틸렌비스포스포네이트, 디에틸디이소부틸메틸렌비스포스포네이트, 디메틸디-n-펜틸메틸렌비스포스포네이트, 디에틸디-n-펜틸메틸렌비스포스포네이트, 디메틸디-n-헥실메틸렌비스포스포네이트, 디메틸디-n-헵틸메틸렌비스-포스포네이트, 디에틸디-n-헥실 메틸렌비스포스포네이트, 디에틸디-n-헵실메틸렌비스포스프네이트, 디-n-프로필 디-n-부틸 메틸렌비스포스포네이트, 디-n-프로필 디-n-펜틸 메틸렌비스포스포네이트, 메틸 트리에틸 메틸렌비스포스포네이트, 메틸 트리-n-프로필 메틸렌비스포스포네이트, 메틸 트리이소프로필 메틸렌비스포스포네이트, 메틸 트리-n-부틸 메틸렌비스포스포네이트, 에틸 트리메틸 메틸렌비스포스포네이트, 에틸트리-n-프로필 메틸렌비스포스포네이트, 에틸트리-n-부틸 메틸렌비스포스포네이트, 메틸트리-n-펜틸렌비스포스포네이트, 메틸트리-n-헵틸메틸렌비스포스포네이트,메틸 트리-n-헵틸 메틸렌비스포스포네이트, 에틸 트리-n-펜틸 메틸렌비스포스포네이트, 에틸 트리-n-헥실 메틸렌비스포스포네이트 및 에틸트리-n-헵틸 메틸렌비스포스포네이트 또는 이들의 혼합물중에서 선택되는 방법.
- 제5항에 있어서, 아민이 디에틸아민, 피폐리딘 및 피롤리딘 중에서 선택되는 방법.
- 제6항에 있어서, 아민이 디에틸아민인 방법.
- 제6항에 있어서, 단계(b)의 반응물질을 약 55 내지 75℃의 온도로 가열하는 방법.
- 제8항에 있어서, 산 촉매가 파라톨루엔 설폰산인 방법.
- 일반식(Ⅰ)의 테트라알킬에테닐리덴비스포스포네이트.상기식에서, R1,R2,R3및 R4는 C1내지 C7직쇄 또는 측쇄 알킬 중에서 독립적으로 선택하고, R1,R2,R3및 R4가 C1내지 C4직쇄 또는 측쇄 알킬일 경우, 이들은 모두 동일한 알킬이 아니다.
- 제10항에 있어서, R1,R2,R3및 R4는 C1내지 C7직쇄 알킬 중에서 독립적으로 선택되는 화합물.
- 제10항에 있어서, 테트라-n-펜틸 에테닐리덴비스포스포네이트, 테트라-n-헥실 에테닐리덴비스포스포네이트, 테트라-n-헵틸 에테닐리덴비스포스포네이트, 디에틸 디부틸 에테닐리덴비스포스포네이트, 디메틸 디-n-프로필 에테닐리덴비스포스포네이트, 디메틸 디이소프로필 에테닐리덴비스포스포네이트, 디메틸 디-n-부틸 에테닐리덴비스포스포네이트, 디에틸 디-n-프로필 에테닐리덴비스포스포네이트, 디에틸 디이소ㅡ로필 에테닐리덴비스포스포네이트, 디에틸 디메틸 에테닐리덴비스포스포네이트, 디에틸 디부틸 에테닐리덴비스포스포네이트, 디에틸 디이소부틸 에테닐리텐비스포스포네이트, 디에틸 디-n-펜틸 에테닐리덴비스포스포네이트, 디메틸 디-n-펜틸 에테닐리덴비스포스포네이트, 디메틸 디-n-헥실 에테닐리텐비스포스포네이트 디메틸 디-n-헵틸 에테닐리덴비스포스포네이트, 디에틸 디-n-헥실 에테닐리덴비스포스포네이트, 디에틸 디-n-헵틸 에테닐리덴비스포스포네이트, 디-n-프로필 디-n-부틸 에테닐리덴비스포스포네이트, 디-n-프로필 디-n-펜틸 에테닐리덴비스포스포네이트, 메틸 트리에틸 에테닐리덴비스포스포네이트, 메틸 트리-n-프로필 에테닐리덴비스포스포네이트, 메틸 트리이소프로필 에테닐리덴비스포스포네이트, 메틸 트리-n-부틸에테닐리덴비스포스포네이트, 에틸 트리 메틸 에테닐리덴비스포스포네이트, 에틸 트리-n-프로필 에테닐리덴비스포스포네이트, 에틸 트리-n-부틸 에테닐리덴비스포스포네이트, 메틸 트리-n-헵틸 에테닐리덴비스포스포네이트, 에틸 트리-n-헥실 에테닐리덴비스포스포네이트 및 메틸 트리-n-헵틸 에테닐리덴비스포스포네이트, 에틸트리-n-펜틸 에테닐리덴비스포스포네이트, 에틸 트리-n-헥실 에테닐리덴비스포스포네이트, 에틸 트리-n-헵틸 에테닐리덴비스포스포네이트중에서 선택되는 화합물.
- 안전한 유효량의 일반식(Ⅰ) 테트라알킬에테닐리덴비스포스포네이트 화합물과 약제학적으로 허용되는 담체로 이루어진 약제학적 조성물.상기식에서, R1,R2,R3및 R4는 C1내지 C7직쇄 또는 측쇄 알킬 중에서 독립적으로 선택한다.
- 제13항에 있어서, 약 0.1 내지 약 95%의 테트라일킬 에테닐리덴비스포스포네이트를 함유하는 약제학적 조성물.
- 제14항에 있어서, 비누, 크림, 캡슐제, 용액제, 구세액, 치마제 또는 샴푸중에서 선택한 형태의 약제학적 조성물.
- 제14항에 있어서, R1,R2,R3및 R4는 C1내지 C7직쇄 알킬 중에서 독립적으로 선택되는 약제학적 조성물.
- 제14항에 있어서, 상기 테트라알킬 에테닐리덴비스포스포네이트가 테트라메틸 에테닐리덴비스포스포네이트, 테트라에틸 에테닐리덴비스포스포네이트, 테트라부틸 에테닐리덴비스포스포네이트, 테트라이소프로필 에테닐리덴비스포스포네이트, 테트라-n-펜틸 에테닐리덴비스포스포네이트, 테트라-n-헥실 에테닐리덴비스포스포네이트, 테트라-n-헵틸 에테닐리덴비스포스포네이트, 디에틸 디부틸 에테닐리덴비스포스포네이트, 디메틸 디-n-프로필 에테닐리덴비스포스포네이트, 디메틸 디이소프로필 에테닐리덴비스포스포네이트, 디메틸 디-n-부틸 에테닐리덴비스포스포네이트, 디에틸 디-n-프로필 에테닐리덴비스포스포네이트, 디에틸 다이소프로필 에테닐리덴비스포스포네이트, 디에틸 디메틸 에테닐리덴비스포스포네이트, 디에틸 디메틸 에테닐리덴비스포스포네이트, 디에틸 디이소부틸 에테닐리덴비스포스포네이트, 디에틸 디-n-펜틸 에테닐리덴비스포스포네이트, 디메틸 디-n-펜틸 에테닐리덴비스포스포네이트, 디메틸 디-n-헵실 에테닐리덴비스포스포네이트, 디에틸 디-n-헥틸 에테닐리덴비스포스포네이트, 디에틸 디-n-헵실 에테닐리덴비스포스포네이트, 디에틸 디-n-헵틸 에테닐리덴비스포스포네이트, 디-n-프로필 디-n-부틸 에테닐리덴비스포스포네이트, 디-n-프로필 디-n-펜틸 에테닐리덴비스포스포네이트, 메틸 트리에틸 에테닐리덴비스포스포네이트, 메틸 트리-n-프로필 에테닐리덴비스포스포네이트, 메틸 트리이소프로필 에테닐리덴비스포스포네이트, 메틸 트리-n-부틸 에테닐리덴비스포스포네이트, 에틸 트리-n-메틸 에테닐리덴비스포스포네이트, 에틸 트리-n-프로필 에테닐리덴비스포스포네이트, 에틸 트리-n-부틸 에테닐리덴비스포스포네이트, 메틸 트리-n-헥실 에테닐리덴비스포스포네이트, 메틸 트리-n-펜틸 에테닐리덴비스포스포네이트, 메틸 트리-n-헵틸 에테닐리덴비스포스포네이트, 에틸 트리-n-펜틸 에테닐리덴비스포스포네이트, 에틸 트리-n-헥실 에테닐리덴비스포스포네이트 및 에틸 트리-n-헵틸 에테닐리덴비스포스포네이트 또는 그의 혼합물 중에서 선택되는 약제학적 조성물.
- 안전한 유효량의 일반식(Ⅰ) 테트라알킬 에테닐리덴비스포스포네이트 화합물을 전염병에 걸린 인간 또는 동물에 투여함을 특징으로 하여, 인간 또는 동물의 전염병을 치료하는 방법.상기식에서, R1,R2,R3및 R4는 C1내지 C7직쇄 또는 측쇄 알킬 중에서 독립적으로 선택한다.
- 제18항에 있어서, 상기 화합물을 약 0.01 내지 약 10,000mg/kg/일의 용량으로 국소투여하는 방법.
- 제18항에 있어서, 상기 화합물을 약 0.01 내지 약 10,000mg/kg/일의 용량으로 경구투여하는 방법.
- 제18항에 있어서, 상기 화합물을 약 0.01 내지 약 10,000mg/kg/일의 용량으로 전신투여하는 방법.
- 제18항에 있어서, 치료할 전염병이 요도감염증인 방법.
- 제18항에 있어서, 치료할 전염병이 위장감염증인 방법.
- 제18항에 있어서, 치료할 전염병이 피부감염증인 방법.
- 제17항에 있어서, 치료할 전염병이 클로스트리듐 퍼핀겐스(Clostridium Perfingens), 스트렙토코쿠스 무탄스(Streptococcus mutans), 에스케리키아 콜라이(Escherichia coli), 스타필로코쿠스 아우레우스(Straphylococcus anreus), 슈도모나스 아에루기노사(Pseudomonas aeruginosa) 및 프로테우스 불가루스(Proteus Vulgarus)중에서 선택된 미생물에 의해 야기되는 방법.
- 제18항에 있어서, R1,R2,R3및 R4가 C1내지 C7직쇄 알킬로 이루어진 그룹중에서 독립적으로 선택되는 방법.
- 제18항에 있어서, 테트라알킬 에테닐리덴비스포스포네이트 화합물이 테트라메틸 에테닐리덴비스포스포네이트, 테트라에틸 에테닐리덴비스포스포네이트, 테트라부틸 에테닐리덴비스포스포네이트, 테트라이소프로필 에테닐리덴비스포스포네이트, 테트라-n-펜메 에테닐리덴비스포스포네이트, 테트라-n-헥실 에테닐리덴비스포스포네이트, 테트라-n-헵틸 에테닐리덴비스포스포네이트, 디에틸 디부틸 에테닐리덴비스포스포네이트, 디메틸 디-n-프로필 에테닐리덴비스포스포네이트, 디메틸 디이소프로필 에테닐리덴비스포스포네이트, 디메틸 디-n-부틸 에테닐리덴비스포스포네이트, 에틸 디-n-프로필 에테닐리덴비스포스포네이트, 디에틸 다이소프로필 에테닐리덴비스포스포네이트, 디에틸 디메틸 에테닐리덴비스포스포네이트, 디에틸 디부틸 에테닐리덴비스포스포네이트, 디에틸 디이소부틸 에테닐리덴비스포스포네이트, 디에틸 디-n-펜틸 에테닐리덴비스포스포네이트, 디메틸 디-n-펜틸 에테닐리덴비스포스포네이트, 디메틸 디-n-헵실 에테닐리덴비스포스포네이트, 디에틸 디-n-헥틸 에테닐리덴비스포스포네이트, 디에틸 디-n-헵실 에테닐리덴비스포스포네이트, 디에틸 디-n-헵틸 에테닐리텐비스포스포네이트, 디-n-프로필 디-n-부틸 에테닐리덴비스포스포네이트, 디-n-프로필 디-n-펜틸 에테닐리덴비스포스포네이트, 메틸 트리에틸 에테닐리덴비스포스포네이트, 메틸 트리-n-프로필 에테닐리덴비스포스포네이트, 메틸 트리이소프로필 에테닐리덴비스포스포네이트, 메틸 트리-n-부틸 에테닐리덴비스포스포네이트, 에틸 트리 메틸 에테닐리덴비스포스포네이트, 에틸 트리-n-프로필 에테닐리덴비스포스포네이트, 에틸 트리-n-부틸 에테닐리덴비스포스포네이트, 메틸 트리-n-헥실 에테닐리덴비스포스포네이트, 메틸 트리-n-펜틸 에테닐리덴비스포스포네이트, 메틸 트리-n-헵틸 에테닐리덴비스포스포네이트, 에틸 트리-n-펜틸 에테닐리덴비스포스포네이트, 에닐 트리-n-헥실 에테닐리덴비스포스포네이트 및 에틸 트리-n-헵틸 에테닐리덴비스포스포네이트 또는 그의 혼합물 중에서 선택되는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79530685A | 1985-11-04 | 1985-11-04 | |
US795.306 | 1985-11-04 | ||
US795,306 | 1985-11-04 | ||
US855,877 | 1986-04-23 | ||
US06/855,877 US4820698A (en) | 1985-11-04 | 1986-04-23 | Antimicrobial agents and process for their manufacture |
US855.877 | 1986-04-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR870004997A true KR870004997A (ko) | 1987-06-04 |
KR950005876B1 KR950005876B1 (ko) | 1995-06-02 |
Family
ID=27121606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019860009273A KR950005876B1 (ko) | 1985-11-04 | 1986-11-04 | 테트라알킬에테닐리덴비스포스포네이트및이의제조방법 |
Country Status (16)
Country | Link |
---|---|
US (1) | US4820698A (ko) |
EP (1) | EP0221611A3 (ko) |
JP (2) | JP2525379B2 (ko) |
KR (1) | KR950005876B1 (ko) |
AU (1) | AU607685B2 (ko) |
CA (1) | CA1291765C (ko) |
DK (1) | DK167809B1 (ko) |
EG (1) | EG18789A (ko) |
FI (1) | FI864462A (ko) |
GB (1) | GB2183652B (ko) |
HK (1) | HK69992A (ko) |
IL (1) | IL80480A (ko) |
NO (1) | NO864378L (ko) |
NZ (1) | NZ218149A (ko) |
PH (1) | PH24524A (ko) |
SG (1) | SG76092G (ko) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089266A (en) * | 1989-10-10 | 1992-02-18 | Merlin Lee | Non-toxic insecticide composition and method for killing specific insects |
FI92465C (fi) * | 1993-04-14 | 1994-11-25 | Risto Tapani Lehtinen | Menetelmä endo-osteaalisten materiaalien käsittelemiseksi |
US5854227A (en) * | 1994-03-04 | 1998-12-29 | Hartmann; John F. | Therapeutic derivatives of diphosphonates |
DE19615812A1 (de) * | 1996-04-20 | 1997-10-23 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation |
US6183757B1 (en) | 1997-06-04 | 2001-02-06 | Procter & Gamble Company | Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing |
US6284259B1 (en) | 1997-11-12 | 2001-09-04 | The Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria |
US6287577B1 (en) | 1997-11-12 | 2001-09-11 | The Procter & Gamble Company | Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria |
US6214363B1 (en) | 1997-11-12 | 2001-04-10 | The Procter & Gamble Company | Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria |
US6190675B1 (en) | 1997-06-04 | 2001-02-20 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria |
US6183763B1 (en) | 1997-06-04 | 2001-02-06 | Procter & Gamble Company | Antimicrobial wipes which provide improved immediate germ reduction |
US6197315B1 (en) | 1997-06-04 | 2001-03-06 | Procter & Gamble Company | Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria |
US6210695B1 (en) | 1997-06-04 | 2001-04-03 | The Procter & Gamble Company | Leave-on antimicrobial compositions |
US5968539A (en) * | 1997-06-04 | 1999-10-19 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria |
US6190674B1 (en) | 1997-06-04 | 2001-02-20 | Procter & Gamble Company | Liquid antimicrobial cleansing compositions |
US7135191B2 (en) | 1997-09-04 | 2006-11-14 | Zsolt Istvan Hertelendy | Urogenital or anorectal transmucosal vaccine delivery system |
US6099853A (en) * | 1997-09-04 | 2000-08-08 | Protein Express | Vaginal suppository vaccine for urogenital infections |
US6287583B1 (en) | 1997-11-12 | 2001-09-11 | The Procter & Gamble Company | Low-pH, acid-containing personal care compositions which exhibit reduced sting |
ES2205930T3 (es) | 1998-12-23 | 2004-05-01 | Bioagency Ag | Uso de acidos bisfosfonatos. |
DE19902924A1 (de) * | 1999-01-26 | 2000-08-03 | Hassan Jomaa | Verwendung von phosphororganischen Verbindungen zur prophylaktischen und therapeutischen Behandlung von Infektionen |
EP1956903B1 (en) * | 2005-11-29 | 2017-01-11 | Ambria Dermatology AB | Use of an absorption product comprising pentane-1, 5-diol as deodorant |
US20090111736A1 (en) * | 2007-10-29 | 2009-04-30 | Sri International | Orally-Absorbed Solid Dose Formulation for Vancomycin |
US8222192B2 (en) * | 2009-06-19 | 2012-07-17 | R&W Medical LLC | Alcohol-based skin cleanser |
WO2013033450A2 (en) * | 2011-08-31 | 2013-03-07 | Mallinckrodt Llc | Remote assembly of targeted nanoparticles using h-phosphonate-ene/-yne hydrophosphonylation reactions |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3062792A (en) * | 1960-03-01 | 1962-11-06 | Eastman Kodak Co | Polymers derived from tetraalkyl vinylidenediphosphonates |
DE1225818B (de) * | 1964-03-18 | 1966-09-29 | Monsanto Co | Verwendung wasserloeslicher Polyphosphonsaeure-verbindungen als Potenzierungsmittel fuer Bakterizide |
GB1204967A (en) * | 1967-05-08 | 1970-09-09 | Monsanto Co | Organic phosphorus compounds, their production and use |
US3576793A (en) * | 1967-05-08 | 1971-04-27 | Monsanto Co | Polymers of alkylene diphosphonic acids and salts and copolymers thereof |
US3544509A (en) * | 1967-05-08 | 1970-12-01 | Monsanto Co | Diphosphonic acids and salts thereof as flame retardants |
US3657282A (en) | 1969-01-23 | 1972-04-18 | Merck & Co Inc | Carboxyepoxyethyl-1-phosphonic acid and derivatives |
-
1986
- 1986-04-23 US US06/855,877 patent/US4820698A/en not_active Expired - Lifetime
- 1986-10-28 EP EP86201890A patent/EP0221611A3/en not_active Withdrawn
- 1986-10-30 PH PH34431A patent/PH24524A/en unknown
- 1986-11-03 FI FI864462A patent/FI864462A/fi not_active Application Discontinuation
- 1986-11-03 NZ NZ218149A patent/NZ218149A/xx unknown
- 1986-11-03 AU AU64679/86A patent/AU607685B2/en not_active Ceased
- 1986-11-03 GB GB8626240A patent/GB2183652B/en not_active Expired
- 1986-11-03 IL IL80480A patent/IL80480A/xx unknown
- 1986-11-03 CA CA000522069A patent/CA1291765C/en not_active Expired - Fee Related
- 1986-11-03 NO NO864378A patent/NO864378L/no unknown
- 1986-11-04 KR KR1019860009273A patent/KR950005876B1/ko not_active IP Right Cessation
- 1986-11-04 DK DK526586A patent/DK167809B1/da not_active IP Right Cessation
- 1986-11-04 JP JP61262597A patent/JP2525379B2/ja not_active Expired - Lifetime
- 1986-11-04 EG EG68486A patent/EG18789A/xx active
-
1992
- 1992-07-28 SG SG760/92A patent/SG76092G/en unknown
- 1992-09-17 HK HK699/92A patent/HK69992A/xx not_active IP Right Cessation
-
1995
- 1995-08-30 JP JP7221730A patent/JP2541794B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH08104634A (ja) | 1996-04-23 |
FI864462A (fi) | 1987-05-05 |
HK69992A (en) | 1992-09-25 |
NZ218149A (en) | 1990-03-27 |
DK526586A (da) | 1987-05-05 |
EP0221611A3 (en) | 1988-01-27 |
GB2183652B (en) | 1989-10-18 |
AU607685B2 (en) | 1991-03-14 |
CA1291765C (en) | 1991-11-05 |
EG18789A (en) | 1995-07-27 |
IL80480A (en) | 1991-12-12 |
KR950005876B1 (ko) | 1995-06-02 |
IL80480A0 (en) | 1987-02-27 |
SG76092G (en) | 1992-10-02 |
DK526586D0 (da) | 1986-11-04 |
GB8626240D0 (en) | 1986-12-03 |
NO864378L (no) | 1987-05-05 |
DK167809B1 (da) | 1993-12-20 |
FI864462A0 (fi) | 1986-11-03 |
US4820698A (en) | 1989-04-11 |
PH24524A (en) | 1990-07-18 |
JP2541794B2 (ja) | 1996-10-09 |
NO864378D0 (no) | 1986-11-03 |
GB2183652A (en) | 1987-06-10 |
JP2525379B2 (ja) | 1996-08-21 |
EP0221611A2 (en) | 1987-05-13 |
JPS62167790A (ja) | 1987-07-24 |
AU6467986A (en) | 1987-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR870004997A (ko) | 테트라알킬 에테닐리덴 비스포스포네이트 및 이의 제조방법 | |
US3950418A (en) | Vitamin A acid amides | |
KR880006193A (ko) | 피페리딘 화합물 및 그의 제조 및 용도 | |
EP0066458B1 (en) | Water-soluble benzothiazine dioxide salts | |
US4031243A (en) | 2-(4-Isobutyl phenyl)butyric acid, salts thereof, and pharmaceutical compositions containing the same | |
IE40511L (en) | Pyridyl piperidine derivatives | |
ES8302001A1 (es) | Un procedimiento para la preparacion de nuevos derivados de cefalospirina. | |
US3458633A (en) | Control of helminthiasis with a series of 2-(w-(2-thienyl)alkyl)-,2-(2-(2-thienyl)vinyl)-,and the corresponding isomeric 3-thienyl derivatives of thiazoline and 5,6-dihydro-4h-1,3-thiazine | |
US3806506A (en) | Furan derivatives,compositions thereof and methods for using same | |
US3320282A (en) | Process for preparing esters of 2-hydroxy-3-(3-indolyl) alkanoic acids | |
ES8401926A1 (es) | Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias. | |
US3531497A (en) | 2,4,5 - triphenyl - (and substituted triphenyl) - 3 - acetonitriles of pyrrole | |
US3953461A (en) | Amino derivatives of thiazolo[5,4-b]pyridine-6-carboxylic acids and esters | |
ES8100249A1 (es) | Un metodo para la preparacion de un compuesto de acido hi- droxamico | |
US4000265A (en) | Method for treating arteriosclerotic and cardiovascular disorders | |
US3658989A (en) | Antibacterial composition containing tetracycline sulfamate and derivatives thereof | |
US4246278A (en) | Medicaments having an antiphlogistic action | |
US4049829A (en) | Sulphur containing hydroxy aliphatic compounds | |
US4038412A (en) | N-(phenylether-substituted benzyl)alkanediamines | |
US3821251A (en) | Disubstituted xanthone carboxylic acid compounds | |
US3129222A (en) | 2, 2, 5-trisubstituted-4-oxazolidinone compounds | |
SE7412163L (ko) | ||
EP0049999A3 (en) | Cyclic compounds and their preparation and use | |
US4210664A (en) | Use of α,α'-dithiobis(β-arylacrylic acid) derivatives to enhance zinc serum and tissue concentrations | |
US3935255A (en) | Phenylacetic acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20020417 Year of fee payment: 8 |
|
LAPS | Lapse due to unpaid annual fee |